Some important updates regarding quality standards and changes to the United States Pharmacopeia (USP) standards are coming that may impact your practice.
To give some background, pharmacies in the Revelation Pharma Network follow standard operating procedures that are built around processes developed by USP. While USP is not a regulatory agency and does not carry the force of law, many state boards of pharmacy as well as the FDA recognize USP’s compounding standards as the measure of quality assurance that a compounding pharmacy should follow.
On November 1, 2023, new editions of USP chapters pertaining to nonsterile, sterile, and hazardous drug compounding will become compendially applicable, meaning that they are the most current versions and regulatory agencies may choose to adopt them.
It is important to note that these new editions are not simple modifications but are largely complete re-writes of the current chapters and represent significant